Business Standard

Lupin extends gain as UK MHRA completes inspection at Goa unit

The stock was up 3% to Rs 798, extending its Monday's 5% surge on the BSE

Lupin receives US FDA for electrolyte replenisher
Premium

SI Reporter Mumbai
Lupin was up 3% to Rs 798, extending its Monday’s 5% surge on the BSE, after the company announced the successful completion of the inspection by the UK MHRA at its Goa facility in March, 2018.

There were no critical or major observations in the inspection, Lupin said in a press release.

"We are committed to maintaining truly global quality standards at our manufacturing units. The successful inspection by UK MHRA is a meaningful development for our Goa plant,” said Nilesh Gupta, Managing Director, Lupin.

On Monday, April 2, Lupin announced the successful facility review carried out

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in